Cargando…
Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
BACKGROUND: Administration of bone marrow mononuclear cells (BMMCs) modulates lung inflammation and fibrosis in experimental silicosis. However, no studies have evaluated whether silicosis affects the efficacy of autologous BMMCs treatment. We hypothesized that BMMCs obtained from healthy or silicot...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681761/ https://www.ncbi.nlm.nih.gov/pubmed/29126438 http://dx.doi.org/10.1186/s13287-017-0699-7 |
_version_ | 1783277974359900160 |
---|---|
author | de Oliveira, Helena D’Anunciação de Melo, Elga Bernardo Bandeira Silva, Johnatas Dutra Kitoko, Jamil Zola Gutfilen, Bianca Barboza, Thiago de Souza, Sergio Augusto Lopes Takiya, Christina Maeda Rocco, Patricia Rieken Macedo Lopes-Pacheco, Miquéias Morales, Marcelo Marcos |
author_facet | de Oliveira, Helena D’Anunciação de Melo, Elga Bernardo Bandeira Silva, Johnatas Dutra Kitoko, Jamil Zola Gutfilen, Bianca Barboza, Thiago de Souza, Sergio Augusto Lopes Takiya, Christina Maeda Rocco, Patricia Rieken Macedo Lopes-Pacheco, Miquéias Morales, Marcelo Marcos |
author_sort | de Oliveira, Helena D’Anunciação |
collection | PubMed |
description | BACKGROUND: Administration of bone marrow mononuclear cells (BMMCs) modulates lung inflammation and fibrosis in experimental silicosis. However, no studies have evaluated whether silicosis affects the efficacy of autologous BMMCs treatment. We hypothesized that BMMCs obtained from healthy or silicotic mice may improve lung function, but they might affect the inflammatory and fibrotic processes differently in experimental silicosis. METHODS: C57BL/6 mice were randomly divided into control (C) and silicosis (SIL) groups. Mice in the SIL group were instilled with silica particles intratracheally; the C animals received saline using the same protocol. On day 15, the animals were treated with saline (Sal) or BMMCs (2 × 10(6) cells) from healthy (BMMC-healthy) and silicotic (BMMC-sil) donors. Lung mechanics were measured, and lungs were collected for histology and molecular biology analysis. RESULTS: BMMCs obtained from healthy and silicotic donors presented similar percentages of cell populations. (99m)Tc-BMMCs tracking revealed preferential migration of cells to the liver, and only a few GFP(+) BMMCs were observed in lung tissue 24 h after treatment, regardless of donor type. Both the SIL-BMMC-healthy and SIL-BMMC-sil groups showed improvement in lung function, a reduction in the fractional area of granuloma, and a decrease in the number of mononuclear and apoptotic cells in lung parenchyma. In addition, the number of F4/80(+) macrophages, the levels of interleukin-1 beta and transforming growth factor beta, and collagen fiber content in granuloma were reduced in SIL-BMMC-healthy mice, whereas mRNA expression of MMP-9 and procollagen I and III was reduced in the SIL-BMMC-sil group. CONCLUSIONS: Administration of BMMCs from healthy and silicotic donors reduced lung inflammation and fibrosis, thus improving lung function. In addition, BMMC-healthy exhibited a greater improvement in lung morpho-functional changes in murine model of silicosis. |
format | Online Article Text |
id | pubmed-5681761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56817612017-11-17 Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice de Oliveira, Helena D’Anunciação de Melo, Elga Bernardo Bandeira Silva, Johnatas Dutra Kitoko, Jamil Zola Gutfilen, Bianca Barboza, Thiago de Souza, Sergio Augusto Lopes Takiya, Christina Maeda Rocco, Patricia Rieken Macedo Lopes-Pacheco, Miquéias Morales, Marcelo Marcos Stem Cell Res Ther Research BACKGROUND: Administration of bone marrow mononuclear cells (BMMCs) modulates lung inflammation and fibrosis in experimental silicosis. However, no studies have evaluated whether silicosis affects the efficacy of autologous BMMCs treatment. We hypothesized that BMMCs obtained from healthy or silicotic mice may improve lung function, but they might affect the inflammatory and fibrotic processes differently in experimental silicosis. METHODS: C57BL/6 mice were randomly divided into control (C) and silicosis (SIL) groups. Mice in the SIL group were instilled with silica particles intratracheally; the C animals received saline using the same protocol. On day 15, the animals were treated with saline (Sal) or BMMCs (2 × 10(6) cells) from healthy (BMMC-healthy) and silicotic (BMMC-sil) donors. Lung mechanics were measured, and lungs were collected for histology and molecular biology analysis. RESULTS: BMMCs obtained from healthy and silicotic donors presented similar percentages of cell populations. (99m)Tc-BMMCs tracking revealed preferential migration of cells to the liver, and only a few GFP(+) BMMCs were observed in lung tissue 24 h after treatment, regardless of donor type. Both the SIL-BMMC-healthy and SIL-BMMC-sil groups showed improvement in lung function, a reduction in the fractional area of granuloma, and a decrease in the number of mononuclear and apoptotic cells in lung parenchyma. In addition, the number of F4/80(+) macrophages, the levels of interleukin-1 beta and transforming growth factor beta, and collagen fiber content in granuloma were reduced in SIL-BMMC-healthy mice, whereas mRNA expression of MMP-9 and procollagen I and III was reduced in the SIL-BMMC-sil group. CONCLUSIONS: Administration of BMMCs from healthy and silicotic donors reduced lung inflammation and fibrosis, thus improving lung function. In addition, BMMC-healthy exhibited a greater improvement in lung morpho-functional changes in murine model of silicosis. BioMed Central 2017-11-10 /pmc/articles/PMC5681761/ /pubmed/29126438 http://dx.doi.org/10.1186/s13287-017-0699-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research de Oliveira, Helena D’Anunciação de Melo, Elga Bernardo Bandeira Silva, Johnatas Dutra Kitoko, Jamil Zola Gutfilen, Bianca Barboza, Thiago de Souza, Sergio Augusto Lopes Takiya, Christina Maeda Rocco, Patricia Rieken Macedo Lopes-Pacheco, Miquéias Morales, Marcelo Marcos Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice |
title | Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice |
title_full | Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice |
title_fullStr | Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice |
title_full_unstemmed | Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice |
title_short | Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice |
title_sort | therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681761/ https://www.ncbi.nlm.nih.gov/pubmed/29126438 http://dx.doi.org/10.1186/s13287-017-0699-7 |
work_keys_str_mv | AT deoliveirahelenadanunciacao therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice AT demeloelgabernardobandeira therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice AT silvajohnatasdutra therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice AT kitokojamilzola therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice AT gutfilenbianca therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice AT barbozathiago therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice AT desouzasergioaugustolopes therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice AT takiyachristinamaeda therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice AT roccopatriciariekenmacedo therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice AT lopespachecomiqueias therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice AT moralesmarcelomarcos therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice |